These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29214511)

  • 41. [Summary of the Dutch College of General Practitioners' "Gout" Standard].
    Romeijnders AC; Gorter KJ
    Ned Tijdschr Geneeskd; 2002 Feb; 146(7):309-13. PubMed ID: 11876034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel uricosurics.
    Bardin T; Richette P
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i42-i46. PubMed ID: 29272511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drugs for gout.
    Med Lett Drugs Ther; 2014 Mar; 56(1438):22-4. PubMed ID: 24791281
    [No Abstract]   [Full Text] [Related]  

  • 44. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.
    Wortmann RL; Macdonald PA; Hunt B; Jackson RL
    Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis and treatment of gout in primary care.
    Rakieh C; Conaghan PG
    Practitioner; 2011 Dec; 255(1746):17-20, 2-3. PubMed ID: 22272526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of gout].
    Dubost JJ; Mathieu S; Soubrier M
    Rev Med Interne; 2011 Dec; 32(12):751-7. PubMed ID: 21382654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An open-label, 6-month study of allopurinol safety in gout: The LASSO study.
    Becker MA; Fitz-Patrick D; Choi HK; Dalbeth N; Storgard C; Cravets M; Baumgartner S
    Semin Arthritis Rheum; 2015 Oct; 45(2):174-83. PubMed ID: 26190562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of Gout and Hyperuricemia in CKD.
    Vargas-Santos AB; Neogi T
    Am J Kidney Dis; 2017 Sep; 70(3):422-439. PubMed ID: 28456346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis and management of gout.
    Pittman JR; Bross MH
    Am Fam Physician; 1999 Apr; 59(7):1799-806, 1810. PubMed ID: 10208700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic challenges in the management of gout in the elderly.
    Singh H; Torralba KD
    Geriatrics; 2008 Jul; 63(7):13-8, 20. PubMed ID: 18593209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention and management of gout.
    Star VL; Hochberg MC
    Drugs; 1993 Feb; 45(2):212-22. PubMed ID: 7681372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diversity of opinions on the management of gout in France. A survey of 750 rheumatologists.
    Rozenberg S; Lang T; Laatar A; Koeger AC; Orcel P; Bourgerois P
    Rev Rhum Engl Ed; 1996 Apr; 63(4):255-61. PubMed ID: 8738444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperuricaemia and gout.
    Shipley M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment and prophylaxis of gout flare in the clinic: an office-based approach to gout management.
    Lieberman JA
    Postgrad Med; 2011 Nov; 123(6):151-65. PubMed ID: 22104464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progress in the pharmacotherapy of gout.
    Sundy JS
    Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment for acute flares of gout: A protocol for systematic review.
    Tang H; Xu G; Zheng Q; Cheng Y; Zheng H; Li J; Yin Z; Liang F; Chen J
    Medicine (Baltimore); 2020 Apr; 99(14):e19668. PubMed ID: 32243400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
    Zhang W; Doherty M; Bardin T; Pascual E; Barskova V; Conaghan P; Gerster J; Jacobs J; Leeb B; Lioté F; McCarthy G; Netter P; Nuki G; Perez-Ruiz F; Pignone A; Pimentão J; Punzi L; Roddy E; Uhlig T; Zimmermann-Gòrska I;
    Ann Rheum Dis; 2006 Oct; 65(10):1312-24. PubMed ID: 16707532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gout--what are the treatment options?
    Schlesinger N; Dalbeth N; Perez-Ruiz F
    Expert Opin Pharmacother; 2009 Jun; 10(8):1319-28. PubMed ID: 19463070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.